1/2상모집 중단 (진행 중)

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

연구 개요

This study is researching an experimental drug called REGN7041 (also referred to as "study drug"). The study is focused on patients who have active inflammation inside of the eye without any signs of infection. The aim of the study is to see how safe and tolerable the study drug is. This is the first time the study drug is being tested in humans. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood and the fluid in the eye at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

스폰서
리드: 리제네론
적응증
Active Noninfectious Uveitis Affecting the Posterior Segment
중재
REGN7041
목표 등록
72
시작일
2025-12-17
완료(예정)
2028-06-28

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.